Virtual Ileostomy Versus Conventional Loop Ileostomy
Rectal Neoplasms
About this trial
This is an interventional treatment trial for Rectal Neoplasms focused on measuring Virtual ileostomy, Diverting ileostomy, Rectal Neoplasms, Rectosigmoid junction
Eligibility Criteria
Inclusion Criteria: Pathologically confirmed low to intermediate level rectal cancer, with the lower margin of anastomosis <10cm from the anus. age ≥18 years and ≤80 years. the surgical procedure is anterior rectal resection (LAR). intraoperative virtual or conventional ileostomy was performed. Exclusion Criteria: BMI >30 kg/m². ASA score >3. Patients with coexisting complete intestinal obstruction. History of long-term use of immunosuppressive drugs or glucocorticoids. Combined severe cardiac disease: with congestive heart failure or NYHA cardiac function ≥ grade 2. Patients with a history of myocardial infarction or coronary artery surgery within 6 months prior to the procedure. chronic renal failure (requiring dialysis or glomerular filtration rate <30 mL/min). Intraoperative combined multi-organ resection. Combined cirrhosis of the liver. Intraoperative findings of incomplete anastomosis and positive insufflation test.
Sites / Locations
- Daping hospital
- Daping Hospital, Third Military Medical University
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Virtual ileostomy
Diverting ileostomy
Laparoscopic or robotic surgery with virtual ileostomy
Laparoscopic or robotic surgery with diverting ileostomy